Which of the following drug is active against Provettela, Porphyromonas gingivalis:
**Question:** Which of the following drug is active against Provettela, Porphyromonas gingivalis:
A. Amoxicillin
B. Metronidazole
C. Cefaclor
D. Tetracycline
**Core Concept:**
Porphyromonas gingivalis is a gram-negative anaerobic bacterium that plays a crucial role in the development of periodontal disease. Provetella is likely a misspelling of Porphyromonas gingivalis. Understanding the pharmacology of antibiotics against this bacterium is essential for treating oral infections and managing periodontal diseases.
**Why the Correct Answer is Right:**
Both Amoxicillin and Metronidazole are active against Porphyromonas gingivalis due to their ability to target specific bacterial enzymes and pathways. Amoxicillin is a penicillin-derived antibiotic that inhibits bacterial cell wall synthesis by targeting the enzyme DD-transpeptidase involved in cross-linking peptidoglycan chains. Metronidazole, a nitroimidazole derivative, targets the bacterial enzyme aldehyde dehydrogenase, which is essential for the cell's energy production through the TCA cycle (Tricarboxylic Acid cycle).
**Why Each Wrong Option is Incorrect:**
Cefaclor is a third-generation cephalosporin antibiotic that primarily targets gram-positive bacteria and is not effective against anaerobic bacteria like Porphyromonas gingivalis. Cefaclor works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs).
Tetracycline is a broad-spectrum antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit, preventing the binding of aminoacyl-tRNA to the ribosome. However, Tetracycline is less effective against anaerobic bacteria, including Porphyromonas gingivalis, which makes it less preferable compared to Amoxicillin and Metronidazole.
**Clinical Pearl:**
In clinical practice, a combination of Amoxicillin and Metronidazole is often prescribed to treat severe periodontal infections caused by Porphyromonas gingivalis due to their complementary mechanisms of action and greater efficacy against anaerobic bacteria.